Introduction
This year, the 27th UEG week was held in Barcelona. Cutting edge results in all the fields of Gastroenterology were presented during the congress. Here we will summarize the main hot results of abstract-based sessions in the endoscopy and hepatology field.
Diagnostic endoscopy is booming hand in hand with new imaging modalities and artificial intelligence (AI)based systems. These tools are not only conceived for endoscopy experts, but also for trainees and population-based screening programs. They are intended to improve the early diagnosis and characterization of endoscopic lesions. However, most of AI-based evidence to date was focused in experimental studies. In this meeting, real-time studies with impressive results have been presented for the very first time. Therapeutic endoscopy has also been widely discussed in Barcelona including new indications, more specialized and dedicated devices, and promising outcomes of endoscopic submucosal dissection and endoscopic-ultrasound guided therapies.
Some interesting points were also discussed within the Hepatology field. Non-alcoholic steatohepatitis (NASH) is currently becoming one of the leading causes of chronic liver disease, cirrhosis and hepatocellular carcinoma (HCC) in western countries. However, effective treatments are still lacking. In this meeting, some promising results about a potential treatment were presented. Moreover, cutting edge data were also presented about the pivotal role of imaging in diagnosis, assessment of prognosis and treatments of chronic liver diseases and primary liver tumors.
Endoscopy
Linked colour imaging better than white light to detect early neoplasms A multicentre randomized control clinical trial (RCT) from China 1 assessed the effectiveness of linked colour imaging (LCI) in early gastric cancer. These authors randomly allocated patients who underwent upper-GI endoscopy into white light (WL) endoscopy alone (n ¼ 914) or combined with LCI (n ¼ 914). LCI achieved a higher accuracy for detecting gastric intestinal metaplasia (88% vs. 68%) and early gastric cancer or high-grade intraepithelial neoplasms (77% vs. 66%) compared to WL alone, suggesting that this modality could improve the diagnostic accuracy in this scenario.
Similarly, Paggi et al., 2 in a multicentre RCT in a colorectal cancer screening programme, analysed the effectiveness of WL compared to LCI. The main aim was the proportion of patients with at least one adenoma. There were 649 randomised patients stratified by gender, age and screening round. The adenoma detection was higher in the LCI group (57% vs. 44%, p ¼ 0.047), without statistically significant differences for the detection of advanced adenomas.
Computer-aided detection help to characterize colorectal lesions
Another RCT 3 comparatively evaluated the adenoma detection rate between colonoscopy with or without the assistance of a real-time computer-aided detection (CAD) system. This trial included 790 patients in two arms and concluded that there were differences in polyp (33% vs. 47%, p < 0.001) and adenoma detection rates (29% vs. 21%, p ¼ 0.009). The AI-aided endoscopic diagnosis systems can also be accurate in the characterization of colorectal lesions in real-time.
A prospective observational study from Japan 4 including 102 polyps in 30 patients, reported that the CAD-system detected 95 polyps (93%) and was able to predict differential diagnosis (neoplastic/non-neoplastic) in 58 polyps from 81 resected with an accuracy and positive predictive value of 87% and 93% respectively. These results may be comparable to endoscopists in a real-time clinical setting.
Regarding indeterminate biliary strictures, singleoperator cholangioscopy guided biopsy is an emerging technique that has shown to be both safe and effective. This procedure has been proposed as an alternative to standard endoscopic retrograde cholangiopancreatography (ERCP) guided brushing. Gerges C et al., 5 in a multicentre RCT including 61 patients, comparatively analysed the diagnostic accuracy of both techniques based on histopathology as gold standard. The sensitivity of SOC-guided biopsies was significantly higher compared to ERCP-guided brushing (68% vs. 21%, p < 0.01), but there were no significant differences in overall accuracy.
Endoscopy-based interventions for the treatment of infected necrotizing pancreatitis reduces complications
Finally, concerning endoscopic ultrasound guided therapies, a systematic review and meta-analysis of three RCTs presented by Bang et al., 6 from USA, compared minimally invasive surgery and endoscopy-based interventions for the treatment of infected necrotizing pancreatitis. The main outcome measures were the complication rate or death during 6-months followup. This study pooled 184 patients concluding that there were no differences in mortality between both approaches (15% vs. 16%, p ¼ 0.96). However, endoscopy-based techniques achieved a lower new onset multiple organ failure (5% vs. 20%, relative risk [RR]: 0.34, p ¼ 0.045), enterocutaneous fistula/perforation (4% vs. 18%, RR ¼ 0.34, p ¼ 0.034) and pancreatic fistula (4% vs. 38%, RR ¼ 0.13, p < 0.001) compared to surgery. Also, the length of hospital stay was lower. These results confirmed that endoscopy significantly reduces complications in patients with infected necrotizing pancreatitis.
Hepatology

Obeticholic acid, a new treatment for NASH
The month 18 pre-specified interim analysis of the ongoing Phase 3 REGENERATE randomized study that evaluates the effect of obeticholic acid (OCA), an FXR agonist, on liver histology in 931 patients with biopsy confirmed NASH was presented during the meeting. 7 Fibrosis primary endpoint (fibrosis improvement (1 stage) with no worsening of NASH) was met by 12% placebo and 23% OCA 25 mg patients (p ¼ 0.0002). Pruritus was the most common adverse event and led to the discontinuation of the drug in 9% of OCA 25 mg treated patients. Thus, treatment with OCA 25 mg improved liver fibrosis and key histologic features of NASH with an overall adverse event rate similar to previous studies.
Identification of risk factors for early portal thrombosis after liver transplantation
A post-hoc analysis of a prospective cohort of 748 patients who underwent liver transplantation (LT) in The Netherlands demonstrated that smoking status and some genetic variation of the donor as well as the presence of NASH in the recipient were associated with early portal thrombosis occurrence. 8 
Assessment of sarcopenia using volumetric computerized tomography
In a retrospective Italian study that included 80 patients who underwent LT, volumetric cut-offs of indexed abdominal muscle volume of 583.7 cm 3 /m 2 for women and 629.9 cm 3 /m 2 for men were associated with sarcopenia and with high risk of death after LT. 9 However, furthers studies are needed to compare the diagnosis performance of the volumetric-CT analysis proposed by the authors to the single-CT slice at L3 level, the actual standard analysis.
Outcome of hepatocellular adenomas (HCA) screened by magnetic resonance imaging (MRI)
A retrospective multicenter study of 118 patients with pathology-proven HCA who underwent MRI surveillance with a median follow-up of 5 years showed that 78% of HCA presented long-term stability or regression. After resection of solitary HCA, tumor progression occurred only in HCA at-risk of malignancy. Patients with multiples HCA were more likely to show progressive disease, with HNF-1a inactivated HCAs being the most common subtype showing progression. 10 This study suggested that the genotype/ phenotype classification based on tissue analysis but also on MRI could be useful to stratify the treatment of patients with HCA in routine.
Liver disorders induced by immunotherapy
In this retrospective study from Japan, 8% of 103 patients (63% of them with lung cancer) treated with Nivolumab and/or Pembrolizumab (anti PD-1/PD-L1 antibody) presented liver disorders (4% of grade 3). Immunotherapy was continued in patients with mild liver disorders without aggravation. The outcome of patients with severe liver disorders was good after discontinuation of the treatment and administration of immunosuppressive agents such as corticosteroids. 11 Thus, early management of liver disorders induced by immune checkpoint inhibitors is associated with a good outcome.
Quick removal of endoscopic biliary drainage after IgG4 related sclerosing cholangitis clinical remission
In this retrospective study of 70 patients with IgG4 related sclerosing cholangitis, Miyazawa et al. suggested that endoscopic biliary drainage removal should be carried out within 2-3 weeks after corticosteroids initiation to prevent endoscopic biliary drainage detachment in patients who achieved clinical remission by corticosteroid treatment. 12 
Conclusion
Despite the immense advances of endoscopy during the last decade, we are witnessing the first steps of a new big data-based endoscopy era, with increasingly dedicated and specialized disciplines and techniques. New approaches in imaging are also improving the care of patients with liver disease. Overall, we are at the beginning of our understanding of NASH physiopathology and, if several treatments seems promising, more data are warranted before their approval and uses in clinical practice. Finally, the recent report about increase overall survival of the combination of atezolizumab (anti PD-L1 inhibitor) and bevacizumab compared to sorafenib in first line treatment of advanced HCC has moved the field of HCC in the exciting era of immunotherapy but also of the era of immune related adverse events in patients with cirrhosis.
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